ArticleGene therapy2019

Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice.

Asha Recino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.